Healio

Navenibart safe, lowers hereditary angioedema attack rate up to 24 months

Among adults with hereditary angioedema, the safety of navenibart up to 24 months was favorable, according to interim trial ...

Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference

Data from the RestorAATion-2 clinical trial of WVE-006 (GalNAc-RNA editing), including new data from the 400 mg multidose cohort and 600 mg ...
Medscape

Novel Drug Navenibart for Hereditary Angioedema So Far Safe, Effective With Quarterly Dosing

Unlike current treatments on the market for hereditary angioedema, navenibart requires dosing only every 3-6 months.
Business Insider

Stoxx Europe 600 Index

Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...